1. Role of adipocytokines in endometrial cancer progression
   Ran Li et al, 2022, Frontiers in Pharmacology CrossRef
2. Association of the Plasminogen Activator Inhibitor-1 (PAI-1) Gene -675 4G/5G and -844 A/G Promoter Polymorphism with Risk of Keloid in a Chinese Han Population
   Yang Sun, 2014, Medical Science Monitor CrossRef
3. The Synergistic Effect of Plasminogen Activator Inhibitor-1 (PAI-1) Polymorphisms and Metabolic Syndrome on Coronary Artery Disease in the Korean Population
   Han Sung Park et al, 2020, Journal of Personalized Medicine CrossRef
4. Mice Deficient in Sfrp1 Exhibit Increased Adiposity, Dysregulated Glucose Metabolism, and Enhanced Macrophage Infiltration
   Kelly J. Gauger et al, 2013, PLoS ONE CrossRef
5. Risk factors for endometrial cancer: An umbrella review of the literature
   Olivia Raglan et al, 2019, International Journal of Cancer CrossRef
6. PAI-1 Polymorphisms Have Significant Associations With Cancer Risk, Especially Feminine Cancer
   Jiaxi Wang et al, 2021, Technology in Cancer Research & Treatment CrossRef
7. Plasminogen activator inhibitor (PAI-1) gene polymorphism (4G/5G) and hepatocellular carcinoma in Egyptian patients
   Nader Nemr et al, 2019, Bulletin of the National Research Centre CrossRef
8. The Association of Plasminogen Activator Inhibitor Type 1 (PAI-1) Level and PAI-1 4G/5G Gene Polymorphism with the Formation and the Grade of Endometrial Cancer
   Malik Ejder Yıldırım et al, 2017, Biochemical Genetics CrossRef